Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
View Full LandscapeTarget Indication
Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Clinical Trial
NCT00704483Last updated: 1/17/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Influenza
Heart Transplantation
Non-alcoholic Fatty Liver Disease (NAFLD)
Meningococcal Meningitis
Axial Spondyloarthritis